2012Hebei Journal of Traditional Chinese MedicineRequires access

Observation of Rujiesan on the treatment of cyclomastopathy

Xu We

Open publisher page 0 citations

Abstract

Objective To observe the clinical therapeutic effect of Rujiesan on the treatment of cyclomastopathy.Methods 160 patients with cyclomastopathy were randomly divided into two groups.80 patients in treatment group were treated by Rujiesan.80 cases in control group were treated by tamoxifen citrate tablets.The course was three weeks in two groups.Results The cure rate was 57.5% in the treatment group,and the total effective rate was 88.8%.The cure rate was 20.0% in the control group,and the total effective rate was 71.3%.The cure rate and the total effective rate in treatment group was higher than that in control group(P0.05).The therapeutic effect in treatment group was superior to that in control group.Syndrome score after treatment was decreased as compared with that before treatment in two groups(P0.05,P0.01).And the treatment group were significantly lower(P0.05).The recurrence rate was 8.7% in treatment group,the recurrence rate was 31.3% in the control group,the recurrence rate of the treatment group was better than the control group(P0.01),the long-term efficacy of the treatment group was better than the control group(P0.01).Conclusion Rujiesan has good therapeutic effect,low recurrence rate and worthy of clinical application on cyclomastopathy.

About this research paper

What this paper is about

Objective To observe the clinical therapeutic effect of Rujiesan on the treatment of cyclomastopathy.Methods 160 patients with cyclomastopathy were randomly divided into two groups.80 patients in treatment group were treated by Rujiesan.80 cases in control group were treated by tamoxifen citrate tablets.The course was three weeks in two groups.Results The cure rate was 57.5% in the treatment group,and the total effective rate was 88.8%.The cure rate was 20.0% in the control group,and the total effective rate was 71.3%.The cure rate and the total effective rate in treatment group was higher than that in control group(P0.05).The therapeutic effect in treatment group was superior to that in control group.Syndrome score after treatment was decreased as compared with that before treatment in two groups(P0.05,P0.01).And the treatment group were significantly lower(P0.05).The recurrence rate was 8.7% in treatment group,the recurrence rate was 31.3% in the control group,the recurrence rate of the treatment group was better than the control group(P0.01),the long-term efficacy of the treatment group was better than the control group(P0.01).Conclusion Rujiesan has good therapeutic effect,low recurrence rate and worthy of clinical application on cyclomastopathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical therapeutic effect of Rujiesan on the treatment of cyclomastopathy.Methods 160 patients with cyclomastopathy were randomly divided into two groups.80 patients in treatment group were treated by Rujiesan.80 cases in control group were treated by tamoxifen citrate tablets.The course was three weeks in two groups.Results The cure rate was 57.5% in the treatment group,and the total effective rate was 88.8%.The cure rate was 20.0% in the control group,and the total effective rate was 71.3%.The cure rate and the total effective rate in treatment group was higher than that in control group(P0.05).The therapeutic effect in treatment group was superior to that in control group.Syndrome score after treatment was decreased as compared with that before treatment in two groups(P0.05,P0.01).And the treatment group were significantly lower(P0.05).The recurrence rate was 8.7% in treatment group,the recurrence rate was 31.3% in the control group,the recurrence rate of the treatment group was better than the control group(P0.01),the long-term efficacy of the treatment group was better than the control group(P0.01).Conclusion Rujiesan has good therapeutic effect,low recurrence rate and worthy of clinical application on cyclomastopathy.

Key concepts: Medicine, Treatment and control groups, Cure rate, Therapeutic effect, Surgery, Clinical efficacy, Conventional treatment, Treatment effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of Rujiesan on the treatment of cyclomastopathy — Research Paper | ScholarLens